THE SAFETY OF RETROVIRAL VECTORS

被引:35
|
作者
GUNTER, KC
KHAN, AS
NOGUCHI, PD
机构
[1] US FDA,CTR BIOL EVALUAT & RES,DIV CELLULAR & GENE THERAPIES,OFF THERAPEUT RES & REV,ROCKVILLE,MD 20852
[2] US FDA,CTR BIOL EVALUAT & RES,DIV VIRAL PROD,OFF VACCINES RES & REVIEW,ROCKVILLE,MD 20852
关键词
D O I
10.1089/hum.1993.4.5-643
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:643 / 645
页数:3
相关论文
共 50 条
  • [41] Assays to evaluate the genotoxicity of retroviral vectors
    Nienhuis, Arthur W.
    MOLECULAR THERAPY, 2006, 14 (04) : 459 - 460
  • [42] Insertional mutagenesis by retroviral and lentiviral vectors
    Bokhoven, Marieke
    Stephen, Sam
    Takeuchi, Yasuhiro
    Collins, Mary K.
    HUMAN GENE THERAPY, 2007, 18 (10) : 958 - 958
  • [43] Retroviral vectors for gene therapy.
    Prassolov, VS
    Ivanov, DS
    VOPROSY MEDITSINSKOI KHIMII, 2000, 46 (03): : 207 - 225
  • [44] Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes
    Zhou, Sheng
    Fatima, Soghra
    Ma, Zhijun
    Wang, Yong-Dong
    Lu, Taihe
    Janke, Laura J.
    Du, Yang
    Sorrentino, Brian P.
    MOLECULAR THERAPY, 2016, 24 (06) : 1090 - 1099
  • [45] TARGETING RETROVIRAL VECTORS TO SPECIFIC CELLS
    KABAT, D
    SCIENCE, 1995, 269 (5222) : 417 - 417
  • [46] Retroviral vectors for human gene therapy
    Ferrari, G
    MINERVA BIOTECNOLOGICA, 1997, 9 (03) : 108 - 116
  • [47] Retroviral vectors and gene therapy: An update
    Maurya, S. K.
    Srivastava, Sushant
    Joshi, R. K.
    INDIAN JOURNAL OF BIOTECHNOLOGY, 2009, 8 (04): : 349 - 357
  • [48] Association of magnetic nanoparticles to retroviral vectors
    Mostegl, M. M.
    FEBS JOURNAL, 2007, 274 : 301 - 301
  • [49] Retroviral vectors: from bench to clinics
    Barquinero, J
    GENE THERAPY, 2004, 11 : S122 - S123
  • [50] Retroviral vectors for cancer gene therapy
    Collins, M
    THERAPEUTIC VACCINATION STRATEGIES, 2000, 30 : 99 - 104